Amlodipine toxicity and lipid emulsion

Article information

Korean J Anesthesiol. 2018;71(6):491-492
Publication date (electronic) : 2018 May 30
doi : https://doi.org/10.4097/kja.d.18.00126
1Department of Anesthesiology and Pain Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
2Department of Anesthesiology and Pain Medicine, Gyeongsang National University Hospital, Gyeongsnag National University School of Medicine, Jinju, Korea
3Institute of Health Sciences, Gyeongsang National University, Jinju, Korea
Corresponding author: Ju-Tae Sohn, M.D. Department of Anesthesiology and Pain Medicine, Gyeongsang National University Hospital, Gyeongsnag National University School of Medicine, 79 Gangnam-ro, Jinju 52727, Korea Tel: 82-55-750-8586, Fax: 82-55-750-8142, Email: jtsohn@gnu.ac.kr
Received 2018 May 14; Accepted 2018 May 22.

We read the interesting article ‘Amlodipine toxicity complicated by concurrent medications’ in the Korean Journal of Anesthesiology [1]. In addition to the supportive treatment of amlodipine toxicity reported by Gupta and Kerai [1], the following should be considered in the treatment and interpretation of this case. First, amlodipine is a dihydropyridine L-type calcium channel blocker and mainly produces vasodilation in the treatment of hypertension [2]. Toxic doses of amlodipine produce not only vasodilation but also severe cardiac depression [2]. It has been reported that lipid emulsion alleviates the severe cardiovascular depression induced by toxic doses of amlodipine [24]. In addition, the widely accepted underlying mechanism associated with lipid emulsion-mediated treatment of local anesthetic toxicity is a scavenging effect (lipid sink and shuttle), in which a drug with high lipid solubility is absorbed into a lipid emulsion of plasma from tissue and then transported into the liver and muscle for detoxification [5]. Moreover, lipid emulsion alone causes a direct inotropic effect [5]. Taking into consideration the above comments, as amlodipine is highly lipid soluble (log [octanol/water partition coefficient]: 3.0) and a toxic dose of amlodipine additionally produces myocardial depression, lipid emulsion treatment should be considered for the treatment of cardiovascular depression induced by a toxic dose of amlodipine [2,5]. Second, Gupta and Kerai [1] emphasized successful treatment of amlodipine toxicity complicated by concurrent medication. Following a suicide attempt using a specific drug, additional agents other than the drug used in the attempt are concurrently administered in some cases of drug toxicity. In some cases of amlodipine toxicity with other concurrent medication (ethanol, simvastatin, and trazodone), as in this case report, lipid emulsion treatment partially contributes to recovery from cardiovascular depression induced by a toxic dose of amlodipine [2,4]. We believe that timely treatment including activated charcoal and supportive care in this case also contributed to recovery from amlodipine-induced cardiovascular depression.

References

1. Gupta B, Kerai S. Amlodipine toxicity complicated by concurrent medications. Korean J Anesthesiol 2018;71:489–90.
2. Meaney CJ, Sareh H, Hayes BD, Gonzales JP. Intravenous lipid emulsion in the management of amlodipine overdose. Hosp Pharm 2013;48:848–54.
3. Karbek Akarca F, Akceylan E, Kıyan S. Treatment of amlodipine intoxication with intravenous lipid emulsion therapy: a case report and review of the literature. Cardiovasc Toxicol 2017;17:482–6.
4. Patel T, Tietze D, Mehta AN. Amlodipine overdose. Proc (Bayl Univ Med Cent) 2013;26:410–1.
5. Fettiplace MR, Weinberg G. The mechanisms underlying lipid resuscitation therapy. Reg Anesth Pain Med 2018;43:138–49.

Article information Continued